Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
In Vivo ; 24(4): 393-400, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20668305

RESUMO

BACKGROUND: The aim of this study was to determine the effects of soy phytoestrogens on the methylation of promoter genes in prostate tumors. The incidence of prostate cancer in Asia is thirty percent lower than in Western countries. Since soy phytoestrogens represent a large portion of the Asian diet, evidence suggests their protective effect against prostate cancer. MATERIALS AND METHODS: In three human prostate cancer cell lines, methylation-specific-PCR was used to determine the effect of soy isoflavones (genistein and daidzein), compared to known demethylating agent 5-azacytidine as control in the promoter regions of glutathione S-transferase P1 (GSTP1), Ras association domain family 1 (RASSF1A), ephrin B2 (EPHB2) and breast cancer 1 (BRCA1) genes. In parallel, immunohistochemistry was used to assess the effects of genistein, daidzein and 5-azacytidine treatment on the corresponding protein expression. RESULTS: All studied promoters, with the exception of that for BRCA1, were strongly methylated without treatment. After treatment by phytoestrogens, demethylation of GSTP1 and EPHB2 promoter regions was observed and an increase in their protein expression was demonstrated by immunohistochemistry. CONCLUSION: Epigenetic modifications of DNA, such as the promoter CpG island demethylation of tumor suppressor genes, might be related to the protective effect of soy on prostate cancer.


Assuntos
Proteína BRCA1/genética , Metilação de DNA/efeitos dos fármacos , Genes BRCA1/efeitos dos fármacos , Glutationa S-Transferase pi/genética , Fitoestrógenos/farmacologia , Regiões Promotoras Genéticas , Neoplasias da Próstata/genética , Receptor EphA2/genética , Proteínas Supressoras de Tumor/genética , Proteína BRCA1/efeitos dos fármacos , Linhagem Celular Tumoral , DNA de Neoplasias/efeitos dos fármacos , DNA de Neoplasias/genética , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Glutationa S-Transferase pi/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Masculino , Regiões Promotoras Genéticas/efeitos dos fármacos , Neoplasias da Próstata/patologia , Receptor EphA2/efeitos dos fármacos , Glycine max , Proteínas Supressoras de Tumor/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...